178 related articles for article (PubMed ID: 25075655)
1. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.
Perdices EV; Medina-Cáliz I; Hernando S; Ortega A; Martín-Ocaña F; Navarro JM; Peláez G; Castiella A; Hallal H; Romero-Gómez M; González-Jiménez A; Robles-Díaz M; Lucena MI; Andrade RJ
Rev Esp Enferm Dig; 2014 Apr; 106(4):246-54. PubMed ID: 25075655
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced liver injury associated with statins.
Russo MW; Scobey M; Bonkovsky HL
Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
Björnsson E; Jacobsen EI; Kalaitzakis E
J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
[TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity of statins and other lipid-lowering agents.
Björnsson ES
Liver Int; 2017 Feb; 37(2):173-178. PubMed ID: 27860156
[TBL] [Abstract][Full Text] [Related]
5. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
[TBL] [Abstract][Full Text] [Related]
6. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
9. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
Ma T; Tien L; Fang CL; Liou YS; Jong GP
Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
[TBL] [Abstract][Full Text] [Related]
10. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
11. [Statins: hepatotoxicity and monitoring].
Cadranel JF; Seddik M; Loric S; Jeanne S
Presse Med; 2009 May; 38(5):717-25. PubMed ID: 19111435
[TBL] [Abstract][Full Text] [Related]
12. Statin-induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis.
Wang LY; Huang YS; Perng CL; Huang B; Lin HC
Br J Clin Pharmacol; 2016 Sep; 82(3):823-30. PubMed ID: 27197051
[TBL] [Abstract][Full Text] [Related]
13. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
Colman E; Szarfman A; Wyeth J; Mosholder A; Jillapalli D; Levine J; Avigan M
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1068-76. PubMed ID: 18821724
[TBL] [Abstract][Full Text] [Related]
15. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
16. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.
Marie I; Delafenêtre H; Massy N; Thuillez C; Noblet C;
Arthritis Rheum; 2008 Mar; 59(3):367-72. PubMed ID: 18311771
[TBL] [Abstract][Full Text] [Related]
17. [Statin-related drug-induced liver injury].
Li XY; Zhong W; Mao YM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):659-663. PubMed ID: 37400395
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians.
Rzouq FS; Volk ML; Hatoum HH; Talluri SK; Mummadi RR; Sood GK
Am J Med Sci; 2010 Aug; 340(2):89-93. PubMed ID: 20588181
[TBL] [Abstract][Full Text] [Related]
19. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain.
Lucena MI; Andrade RJ; Fernández MC; Pachkoria K; Pelaez G; Durán JA; Villar M; Rodrigo L; Romero-Gomez M; Planas R; Barriocanal A; Costa J; Guarner C; Blanco S; Navarro JM; Pons F; Castiella A; Avila S;
Hepatology; 2006 Oct; 44(4):850-6. PubMed ID: 17006920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
